Additionally, clinical studies have identified a correlation between elevated VCP expression and the progression, prognosis, and metastatic potential of esophageal carcinoma [14], colorectal carcinoma [15], and prostate cancer [16]. This evidence concerns the gene VCP and carcinoma of esophagus.